BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7891510)

  • 1. Gastric adenocarcinoma in a patient re-infected with H. pylori after regression of MALT lymphoma with successful anti-H. pylori therapy and gastric resection: a case report.
    Ghoshal UC; Guha D; Bandyopadhyay S; Pal C; Chakraborty S; Ghoshal U; Ghosh TK; Pal BB; Banerjee PK
    BMC Gastroenterol; 2002; 2():6. PubMed ID: 11914140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastrointestinal mucosa-associated lymphoma].
    Fischbach W; Neubauer A; Reinartz G
    Inn Med (Heidelb); 2024 Jul; 65(7):690-700. PubMed ID: 38833003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Helicobacter pylori infection after surgery is unnecessary.
    Lee YT; Chan FK; Sung JJ
    BMJ; 1998 Jun; 316(7148):1904-5. PubMed ID: 9632426
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of primary hepatic mucosa-associated lymphoid tissue lymphoma incidentally found in the sustained virological response state of chronic hepatitis C: review of the literature of this rare disease.
    Yasuda T; Nakagawa S; Imai K; Okabe H; Hayashi H; Yamashita YI; Chikamoto A; Ozono K; Mikami Y; Baba H
    Int Cancer Conf J; 2020 Apr; 9(2):59-65. PubMed ID: 32257755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hepatic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: A case report and literature review.
    Dong S; Chen L; Chen Y; Chen X
    Medicine (Baltimore); 2017 Mar; 96(13):e6305. PubMed ID: 28353562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Helicobacter pylori eradication in patients on NSAID treatment.
    Vonkeman HE; Deleest H; van Delaar M; Vanbaarlen J; Steen K; Lems W; Bijlsma J; Kuipers E; Houben H; Janssen M; Dijkmans B
    BMC Gastroenterol; 2012 Sep; 12():133. PubMed ID: 23006807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection.
    Kobayashi M; Lee H; Nakayama J; Fukuda M
    Glycobiology; 2009 May; 19(5):453-61. PubMed ID: 19150806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of gastric mucosa associated lymphoid tissue lymphoma.
    Morgner A; Schmelz R; Thiede C; Stolte M; Miehlke S
    World J Gastroenterol; 2007 Jul; 13(26):3554-66. PubMed ID: 17659705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma.
    Mueller A; O'rourke J; Chu P; Chu A; Dixon MF; Bouley DM; Lee A; Falkow S
    Am J Pathol; 2005 Sep; 167(3):797-812. PubMed ID: 16127158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research.
    Satoh K
    J Gastroenterol; 2002; 37 Suppl 13():34-8. PubMed ID: 12109663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody responses to Helicobacter pylori and the cagA marker in patients with mucosa-associated lymphoid tissue lymphoma.
    Taupin A; Occhialini A; Ruskone-Fourmestraux A; Delchier JC; Rambaud JC; Mégraud F
    Clin Diagn Lab Immunol; 1999 Jul; 6(4):633-8. PubMed ID: 10391879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice.
    Enno A; O'Rourke J; Braye S; Howlett R; Lee A
    Am J Pathol; 1998 Jun; 152(6):1625-32. PubMed ID: 9626066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication.
    Yang HB; Sheu BS; Su IJ; Chien CH; Lin XZ
    Dig Dis Sci; 1997 Sep; 42(9):1835-40. PubMed ID: 9331144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication.
    Montalban C; Manzanal A; Boixeda D; Redondo C; Bellas C
    Lancet; 1995 Mar; 345(8952):798-9. PubMed ID: 7891510
    [No Abstract]   [Full Text] [Related]  

  • 16. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
    Alpen B; Röbbecke J; Wündisch T; Stolte M; Neubauer A
    Ann Hematol; 2001; 80 Suppl 3():B106-7. PubMed ID: 11757689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
    Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E
    Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.